FIELD: organic chemistry, medicine, pharmacy, chemical technology.
SUBSTANCE: invention relates to novel substituted esters of 1,2,3,7-tetrahydropyrrolo[3,2-f][1,3]benzoxazin-5-carboxylic acids of the general formula (1): or their racemates, or their optical isomers, or their pharmaceutically acceptable salts and/or hydrates possessing the antiviral effect. In compounds of the general formula (1) each R1 and R4 represents independently of one another a substitutes of amino group chosen from hydrogen atom, optionally substituted linear or branched alkyl comprising 1-4 carbon atoms, optionally substituted cycloalkyl comprising 3-10 carbon atoms, optionally substituted aryl or optionally substituted and possibly an annelated heterocyclyl that can be aromatic or nonaromatic and comprising from 3 to 10 atoms in ring with one or some heteroatoms chosen from nitrogen, oxygen or sulfur atoms or their oxides; R2 represents alkyl substitute chosen from hydrogen atom, optionally substituted mercapto group, optionally substituted amino group, optionally substituted hydroxyl; R3 represents lower alkyl or cycloalkyl; R5 represents a substitute of cyclic system chosen from hydrogen atom, optionally substituted linear or branched alkyl comprising 3-12 carbon atoms, optionally substituted cycloalkyl comprising 3-10 carbon atoms, optionally substituted aryl or optionally substituted and optionally an annelated heterocyclyl that can be aromatic or nonaromatic and comprising from 3 to 10 atoms in ring with one or some heteroatoms chosen from nitrogen, oxygen or sulfur atoms or their oxides; R6 represents a substitute of cyclic system chosen from hydrogen atom, halogen atom, cyano group, optionally substituted aryl or optionally substituted and optionally annelated heterocyclyl that can be aromatic or nonaromatic and comprising from 3 to 10 atoms in ring with one or some heteroatoms chosen from nitrogen, oxygen or sulfur atoms or their oxides. Also, invention relates to methods for treatment, drugs and pharmaceutical compositions using compounds of this invention. Proposed compounds can be used as active components of drugs used in treatment of such diseases as infectious hepatitis, human immunodeficiency, atypical pneumonia and avian influenza.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition, improved methods of synthesis.
22 cl, 3 tbl, 6 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
ACTIVE SUBCTANCES, PHARMACEUTICAL COMPOSITION, METHOD OF THEIR PRODUCTION AND APPLICATION | 2007 |
|
RU2332421C1 |
SUBSTITUTED ESTERS OF 1H-INDOL-3-CARBOXYLIC ACID, PHARMACEUTICAL COMPOSITION, METHOD FOR THEIR PREPARING AND USING | 2006 |
|
RU2323210C9 |
FURO- AND THIENO[2,3-b]-QUINOLINE-2-CARBOXAMIDES, METHOD OF PRODUCTION AND ANTITUBERCULOUS ACTIVITY | 2008 |
|
RU2371444C1 |
ACTIVE SUBSTANCES, PHARMACEUTICAL COMPOSITION, METHOD OF OBTAINING AND APPLICATION | 2007 |
|
RU2338531C1 |
ANNELATED AZAHETEROCYCLIC AMIDES, WHICH INCLUDE PYRIMIDINE FRAGMENT, METHOD OF OBTAINING AND THEIR APPLICATION | 2007 |
|
RU2345996C1 |
SUBSTITUTED 3,5-DIAMINO-4-SULFONYL-PYRAZOLES AND 2-AMINO-3-SULFONYL-PYRAZOLO-[1,5-a]PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT RECEPTORS, METHODS FOR THEIR PRODUCTION AND USE | 2008 |
|
RU2376291C1 |
1-OXO-3-(1H-INDOL-3-YL)-1,2,3,4-TETRAHYDROISOQUINOLINES, METHODS OF PREPARATION THEREOF, COMBINATORY LIBRARY, AND FOCUSED LIBRARY | 2006 |
|
RU2302417C1 |
SUBSTITUTED INDOLES, ANTIVIRAL ACTIVE COMPONENT, SYNTHESIS AND APPLICATION METHOD | 2010 |
|
RU2436786C1 |
SUBSTITUTED 4-SULPHONYL-PYRAZOLES AND 3-SULPHONYL-PYRAZOLO[1,5-a]PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT RECEPTORS, ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, MEDICINAL AGENT AND METHOD OF OBTAINING THEM | 2008 |
|
RU2369600C1 |
ANELLATED CABAMOYLAZAHETEROCYCLES, FOCUSED LIBRARY, PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 2005 |
|
RU2281947C1 |
Authors
Dates
2008-04-27—Published
2006-05-23—Filed